271 related articles for article (PubMed ID: 32737302)
1. Signatures of co-deregulated genes and their transcriptional regulators in colorectal cancer.
Mastrogamvraki N; Zaravinos A
NPJ Syst Biol Appl; 2020 Jul; 6(1):23. PubMed ID: 32737302
[TBL] [Abstract][Full Text] [Related]
2. Signatures of Co-Deregulated Genes and Their Transcriptional Regulators in Lung Cancer.
Chatziantoniou A; Zaravinos A
Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142846
[TBL] [Abstract][Full Text] [Related]
3. Signatures of Co-Deregulated Genes and Their Transcriptional Regulators in Kidney Cancers.
Ioannou I; Chatziantoniou A; Drenios C; Christodoulou P; Kourti M; Zaravinos A
Int J Mol Sci; 2023 Mar; 24(7):. PubMed ID: 37047552
[TBL] [Abstract][Full Text] [Related]
4. Identification of Prognostic Biomarker Signatures and Candidate Drugs in Colorectal Cancer: Insights from Systems Biology Analysis.
Rahman MR; Islam T; Gov E; Turanli B; Gulfidan G; Shahjaman M; Banu NA; Mollah MNH; Arga KY; Moni MA
Medicina (Kaunas); 2019 Jan; 55(1):. PubMed ID: 30658502
[TBL] [Abstract][Full Text] [Related]
5. The identification of a common different gene expression signature in patients with colorectal cancer.
Zhao ZW; Fan XX; Yang LL; Song JJ; Fang SJ; Tu JF; Chen MJ; Zheng LY; Wu FZ; Zhang DK; Ying XH; Ji JS
Math Biosci Eng; 2019 Apr; 16(4):2942-2958. PubMed ID: 31137244
[TBL] [Abstract][Full Text] [Related]
6. Integrated bioinformatics analysis for the screening of hub genes and therapeutic drugs in ovarian cancer.
Yang D; He Y; Wu B; Deng Y; Wang N; Li M; Liu Y
J Ovarian Res; 2020 Jan; 13(1):10. PubMed ID: 31987036
[TBL] [Abstract][Full Text] [Related]
7. Identifying the key genes and microRNAs in colorectal cancer liver metastasis by bioinformatics analysis and in vitro experiments.
Zhang T; Guo J; Gu J; Wang Z; Wang G; Li H; Wang J
Oncol Rep; 2019 Jan; 41(1):279-291. PubMed ID: 30542696
[TBL] [Abstract][Full Text] [Related]
8. Delineating the underlying molecular mechanisms and key genes involved in metastasis of colorectal cancer via bioinformatics analysis.
Qi C; Chen Y; Zhou Y; Huang X; Li G; Zeng J; Ruan Z; Xie X; Zhang J
Oncol Rep; 2018 May; 39(5):2297-2305. PubMed ID: 29517105
[TBL] [Abstract][Full Text] [Related]
9. Identification of Key Genes in Colorectal Cancer Regulated by miR-34a.
Wang T; Xu H; Liu X; Chen S; Zhou Y; Zhang X
Med Sci Monit; 2017 Dec; 23():5735-5743. PubMed ID: 29197895
[TBL] [Abstract][Full Text] [Related]
10. Integrative Gene Expression Profiling Analysis to Investigate Potential Prognostic Biomarkers for Colorectal Cancer.
Liu X; Bing Z; Wu J; Zhang J; Zhou W; Ni M; Meng Z; Liu S; Tian J; Zhang X; Li Y; Jia S; Guo S
Med Sci Monit; 2020 Jan; 26():e918906. PubMed ID: 31893510
[TBL] [Abstract][Full Text] [Related]
11. Profiles of differentially expressed genes and overexpression of NEBL indicates a positive prognosis in patients with colorectal cancer.
Qiu X; Feng JR; Wang F; Chen PF; Chen XX; Zhou R; Chang Y; Liu J; Zhao Q
Mol Med Rep; 2018 Feb; 17(2):3028-3034. PubMed ID: 29257257
[TBL] [Abstract][Full Text] [Related]
12. A network-based predictive gene expression signature for recurrence risks in stage II colorectal cancer.
Yang WJ; Wang HB; Wang WD; Bai PY; Lu HX; Sun CH; Liu ZS; Guan DK; Yang GW; Zhang GL
Cancer Med; 2020 Jan; 9(1):179-193. PubMed ID: 31724326
[TBL] [Abstract][Full Text] [Related]
13. Identification of key pathways and genes in colorectal cancer using bioinformatics analysis.
Liang B; Li C; Zhao J
Med Oncol; 2016 Oct; 33(10):111. PubMed ID: 27581154
[TBL] [Abstract][Full Text] [Related]
14. Exploring molecular markers and drug candidates for colorectal cancer through comprehensive bioinformatics analysis.
Li G; Zhu J; Zhai L
Aging (Albany NY); 2023 Jul; 15(14):7038-7055. PubMed ID: 37466419
[TBL] [Abstract][Full Text] [Related]
15. CDK1 and CDC20 overexpression in patients with colorectal cancer are associated with poor prognosis: evidence from integrated bioinformatics analysis.
Li J; Wang Y; Wang X; Yang Q
World J Surg Oncol; 2020 Mar; 18(1):50. PubMed ID: 32127012
[TBL] [Abstract][Full Text] [Related]
16. Identification of a five-gene signature with prognostic value in colorectal cancer.
Sun G; Li Y; Peng Y; Lu D; Zhang F; Cui X; Zhang Q; Li Z
J Cell Physiol; 2019 Apr; 234(4):3829-3836. PubMed ID: 30132881
[TBL] [Abstract][Full Text] [Related]
17. Identification of key gene modules and genes in colorectal cancer by co-expression analysis weighted gene co-expression network analysis.
Wang P; Zheng H; Zhang J; Wang Y; Liu P; Xuan X; Li Q; Du Y
Biosci Rep; 2020 Sep; 40(9):. PubMed ID: 32815531
[TBL] [Abstract][Full Text] [Related]
18. Identification of Critical Genes and Five Prognostic Biomarkers Associated with Colorectal Cancer.
Huang Z; Yang Q; Huang Z
Med Sci Monit; 2018 Jul; 24():4625-4633. PubMed ID: 29973580
[TBL] [Abstract][Full Text] [Related]
19. Hub Genes and Key Pathway Identification in Colorectal Cancer Based on Bioinformatic Analysis.
Lv J; Li L
Biomed Res Int; 2019; 2019():1545680. PubMed ID: 31781593
[TBL] [Abstract][Full Text] [Related]
20. Transcriptome analysis in primary colorectal cancer tissues from patients with and without liver metastases using next-generation sequencing.
Wang S; Zhang C; Zhang Z; Qian W; Sun Y; Ji B; Zhang Y; Zhu C; Ji D; Wang Q; Sun Y
Cancer Med; 2017 Aug; 6(8):1976-1987. PubMed ID: 28745433
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
